[Therapeutic strategies for type 2 diabetes].
The results of the large therapeutic trials for type 2 diabetes have led to a reconsideration of the "classical" treatment strategy. Until now, the strategy consisted of starting with a modification of the lifestyle, then in the event of failure, without privileging one therapeutic class over another, to prescribe a monotherapy, in increasing doses until the maximum dose is reached, and only then to pass to a bi-therapy up to it's maximum dose; Since the apparition of the glitazones, bi-therapy based in particular on the association metformin-glitazone, should be envisaged from diagnosis in patients who are obese or heavily overweight. New strategies now in the process of being elaborated suggest to treat type 2 diabetes much earlier and with much more ambitious glycaemic objectives.